Premium
Successful multi‐target therapy including rituximab and mycophenolate mofetil in anti‐melanoma differentiation‐associated gene 5 antibody‐positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis
Author(s) -
Hisanaga Jumpei,
Kotani Takuya,
Fujiki Youhei,
Yoshida Shuzo,
Takeuchi Tohru,
Makino Shigeki
Publication year - 2017
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/1756-185x.13136
Subject(s) - medicine , mycophenolate , rituximab , interstitial lung disease , dermatomyositis , antibody , lung , immunology , oncology , pathology , transplantation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom